Colorado BioScience Association
Colorado BioScience Association

Thirty Regional Companies Selected to Present at the 2011 Rocky Mountain Life Science Investor Conference in Denver

The 2011 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) will bring 30 of the region’s most innovative private and public life science companies together to present to a targeted audience of biotech, device, diagnostic and pharma investors and strategic partners. The conference is being held September 21-22 at The Brown Palace Hotel, Denver, CO.

Denver, CO, August 10, 2011 --( Thirty regional companies have been chosen to present at the 2011 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC), September 21-22, at The Brown Palace Hotel in Denver, Colorado. The announcement is made by Holli Riebel (formerly Baumunk), President and CEO of the Colorado Bioscience Association (CBSA) on behalf of the RMLIPC Selection Committee, who says the presenting companies were selected from more than 50 applicants by a committee of investors, industry experts and representatives from partnering state bioscience associations.

"Our association spearheads the investor and partnering conference every other year for the region. This is our second event, and we have been absolutely thrilled at the response from both companies applying to present and investors desiring to attend. At this time we've had more than 50 national investment firms indicate attendance and the number is growing daily," Riebel said. "We are again pleased to announce that Johnson & Johnson Development Corporation is the Founding Partner for the conference."

The following 30 companies will present at the 2011 RMLIPC:

AktiVax, Inc, Boulder, CO
Altheus Therapeutics, Inc. Oklahoma City, OK
Andarix Pharmaceuticals Boulder, CO
Avisa Pharma Inc Santa Fe, NM
Azano Pharmaceuticals, Inc. Albuquerque, NM
BaroFold Inc. Aurora, CO
Biodesix, Inc. Broomfield, CO
BiOptix, Inc. Boulder, CO
B-Siege Biotechnologies Denver, CO
Clarimedix Boulder, CO
DermaMedics LLC Oklahoma City, OK
Flashback Technologies Inc. Boulder, CO
Fluonic Aurora, CO
GlobeImmune Inc. Louisville, CO
Inviragen, Inc. Fort Collins, CO
Kane Biotech Inc. Winnipeg, Manitoba CA
KromaTiD, Inc. Fort Collins, CO
MBC Pharma, Inc Aurora, CO
Mitomics Aurora, CO
Mosaic Biosciences, Inc. Boulder, CO
Oncotherix Aurora, CO
PeptiVir, Inc. Aurora, CO
SAJE Pharma, LLC Kalispell, MT
Sharklet Technologies, Inc. Aurora, CO
Sinapis Pharma Missoula, MT
Siva Therapeutics Inc Boulder, CO
SomaLogic, Inc. Boulder, CO
Sophono Boulder, CO
ValveXchange Aurora, CO
VetDC, Inc. Fort Collins, CO

About The Rocky Mountain Life Science Investor and Partnering Conference

The Rocky Mountain region is the largest and most advanced area between both coasts, garnering more than $11.5 billion dollars in financing and acquisitions since the end of 2007. The second Rocky Mountain Life Science Investor & Partnering Conference is building upon the success of the inaugural conference in 2009 to showcase the future of the industry. Engaging companies, investors and representatives from Arizona, Colorado, Montana, New Mexico, Oklahoma, Utah and Canada, the conference will open with a reception at the Colorado Governor’s Mansion September 21st and follow with a full day of company presentations and keynote speakers including Peter A. Gottlieb, MD, Professor of Pediatrics and Medicine Barbara Davis Center at the University of Colorado; Karin Hehenberger M.D., Ph.D., Senior Vice President, Strategic Alliances at the Juvenile Diabetes Research Foundation; and Roy Davis, President of Johnson & Johnson Corporate Development. For more information and registration details, visit

About Colorado BioScience Association

The CBSA is a not-for-profit corporation providing services and support for Colorado's growing biosciences industry. With more than 350 members, CBSA actively works to promote the growth of the industry by working for a better business environment, grow the state's biotech workforce, fight for policies that support a strong bioscience industry in the state and speak with a single voice on behalf of the industry. For more information, visit


April Giles, Executive Vice President, Colorado BioScience Association, 303-592-4071 or

Maggie Chamberlin Holben, APR, Absolutely Public Relations - – 303-984-9801 or

Colorado BioScience Association
Maggie Holben